Tumour lysis following hydrocortisone prior to a blood product transfusion in T-cell acute lymphoblastic leukaemia.
The acute tumour lysis syndrome is a well recognised complication of chemotherapy for lymphoid malignancies. There are few reports, however, of this complication after corticosteroid therapy alone. We report a case of T-cell acute lymphoblastic leukaemia who developed the biochemical picture of tumour lysis after two doses of hydrocortisone given prior to platelet transfusion. Prophylactic corticosteroids prior to blood product infusion should be reserved for patients who have experienced febrile or allergic reactions in the past and it is suggested that they should only be administered to patients with active lymphoid malignancies with due caution.
Tiley
C
C
Leukaemia Unit, Royal Marsden Hospital, Sutton, Surrey, UK.
Grimwade
D
D
Findlay
M
M
Treleaven
J
J
Height
S
S
Catalano
J
J
Powles
R
R
D000293:Adolescent; D016913:Blood Component Transfusion; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000473:pathology / Q000628:therapy*; D008297:Male; D015275:Tumor Lysis Syndrome / Q000209:etiology*
D006854:Hydrocortisone